Windlas Biotech IPO: Check grey market premium, last subscription date of public issue

Windlas Biotech Limited, a leading manufacturer in pharmaceutical designs, launched its initial public offering (IPO) today (4 August). This...

Windlas Biotech Limited, a leading manufacturer in pharmaceutical designs, launched its initial public offering (IPO) today (4 August). This IPO will be open for subscriptions for three consecutive days and it will close on 6 August.

Meanwhile, the price band for the IPO stood at Rs 448 to Rs 460 per equity share, while the grey market premium (GMP) was Rs 130 on 4 August. The shares were therefore trading at a premium of Rs 578 to Rs 590 per equity on the unlisted market.

Windlas Biotech, which was incorporated in 2001, offers a wide range of contract development and manufacturing organisation (CDMO) services. These include services ranging from product discovery to product development like licensing, and commercial manufacturing of generic products as well as complex generics.

Through its public offerings, Windlas Biotech is looking to raise up to Rs 401.54 crore. The issue will reportedly comprise a fresh issue that aggregates up to Rs 165 crore with 5,142,067 equity shares with a face value of Rs 5 per share.

Meanwhile, VP of Research from Religare Broking, Ajit Mishra stated that the company is well placed to grab opportunities arising from the industry and strengthen its relationship with customers.

“Windlas is one of the leaders in the domestic pharmaceutical formulations CDMO industry. We believe the company is well placed to grab the opportunity arising from the industry given its strong product portfolio, relationship with its customers, R&D capabilities, and efficient & quality compliant manufacturing facilities,” Mishra said in a note as per a News18 report.

Additionally, the company is also planning to purchase equipment required for capacity expansion at its Dehradun Plant IV with the IPO. The company has also decided to add injectable dosage capabilities at its other existing plant, Dehradun Plant-II.

Later on, portions of the IPO funds will be used towards the working capital requirements of Windlas and also towards repayment and pre-payment of the firm’s borrowings that have taken place so far.

Read Also
Name

Article,3,ASE News,2,BBC News - Technology,44,Business,23,codecanyon,3,DPR,1,Education / Employment,1,Entertainment,10,General knowledge,2,IANS – The Siasat Daily,8,IFTTT,49,India news,1701,Latest news,1,Madhy Pradesh,465,main,19,National,162,News,1,PTI – The Siasat Daily,3,Sports,11,themeforest,1,World,22,World News,594,
ltr
item
India World News: Windlas Biotech IPO: Check grey market premium, last subscription date of public issue
Windlas Biotech IPO: Check grey market premium, last subscription date of public issue
India World News
https://www.asenews.page/2021/08/windlas-biotech-ipo-check-grey-market.html
https://www.asenews.page/
https://www.asenews.page/
https://www.asenews.page/2021/08/windlas-biotech-ipo-check-grey-market.html
true
8343353446356446311
UTF-8
Loaded All Posts Not found any posts VIEW ALL Readmore Reply Cancel reply Delete By Home PAGES POSTS View All RECOMMENDED FOR YOU LABEL ARCHIVE SEARCH ALL POSTS Not found any post match with your request Back Home Sunday Monday Tuesday Wednesday Thursday Friday Saturday Sun Mon Tue Wed Thu Fri Sat January February March April May June July August September October November December Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec just now 1 minute ago $$1$$ minutes ago 1 hour ago $$1$$ hours ago Yesterday $$1$$ days ago $$1$$ weeks ago more than 5 weeks ago Followers Follow THIS PREMIUM CONTENT IS LOCKED STEP 1: Share to a social network STEP 2: Click the link on your social network Copy All Code Select All Code All codes were copied to your clipboard Can not copy the codes / texts, please press [CTRL]+[C] (or CMD+C with Mac) to copy Table of Content